Pfizer, 2025: Pre-clinical study entitled:  “AI-PRO and AI-DEA: Artificial Intelligence for Patient-Reported Outcomes and Deployment of EPC Access” (Tracking Number 97065955) PI: Prof. Leonardo Potenza